CLSA, the trade association representing California’s life sciences sector, today announced the opening of an expanded office and events center in San Francisco, which is home to many of the top life sciences companies in the state.
CLSI today named Presentation High School Sophomore Shloka Janapaty of San Jose, CA as the winner of CLSI’s 2018 Amgen Bay Area BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field.
OCTANe, Orange County’s life sciences and technology accelerator and California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today announced the Life Sciences Growth Accelerator Program – a unique dual membership program designed to address the specific growth challenges of emerging life sciences companies.
Legislators Honored with Award for Commitment to Strengthening California Life Sciences Sector at CLSA’s Back to Session Reception in Sacramento
CLSA, the trade association representing California’s life sciences industry, today commended the U.S. Senate’s confirmation of Alex Azar as the new secretary of the U.S. Department of Health and Human Services (HHS).
California Life Sciences Association (CLSA) applauds the House and Senate passage of legislation that temporarily suspends the ill-conceived 2.3% medical device tax for an additional 2 years, until December 2019.
CLSA today issued the following statement applauding Governor Jerry Brown’s 2018 – 2019 California budget proposal that calls for $30 million to be invested in precision medicine research and the establishment of the California Institute to Advance Precision Health and Medicine (CIAPHM).
California Life Sciences Association (CLSA) welcomes the introduction of H.R. 4617, legislation that places a 5-year freeze on the ill-conceived 2.3% medical device excise tax. Without swift enactment of this measure, the medical device tax would further hamper innovation and investment in medical technology research and development.
California Life Sciences Association (CLSA) and PwC US newly released annual California Life Sciences Industry Report, provides a snapshot of the largest life sciences cluster in the world. The 2018 report shows that California continues to outpace other states in life science-related economic growth, including venture funding, National Institutes of Health (NIH) funding, digital health venture funding, and is producing nearly 300,000 jobs and shepherding more than a thousand new therapies through the pipeline.
For over 7 years, CLSA has advocacted for repeal of IPAB because such blunt cost containment approaches could seriously harm the delicate cycle of biomedical innovation by reducing incentives for investment in new research and product development, and ultimately limit patient access to lifesaving treatments, therapies and technologies.